Akknatek provides solutions for ophthalmology, with the aim of improving cataract surgery.
Akknatek's investors include European Innovation Council, Luminate.
Akknatek is headquartered in Kaiserslautern, Germany.
Akknatek provides solutions for ophthalmology, with the aim of improving cataract surgery.
Akknatek is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akknatek — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/akknatek. Accessed July 20, 2026.
VCBacked. (2022). Akknatek — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/akknatek
{{cite web |title=Akknatek — Funding & Investors |url=https://www.vcbacked.co/company/akknatek |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated